74 related articles for article (PubMed ID: 7330642)
1. [The differential diagnosis of hypercalcitoninism].
Dambacher MA; Born W; Heitz PU; Olah AJ; Tobler PH; Fischer JA
Schweiz Med Wochenschr; 1981 Dec; 111(49):1897-901. PubMed ID: 7330642
[TBL] [Abstract][Full Text] [Related]
2. Some thoughts on the nature of ectopic parathyroid hormones.
Roof BS; Carpenter B; Fink DJ; Gordan GS
Am J Med; 1971 May; 50(5):686-91. PubMed ID: 5575550
[No Abstract] [Full Text] [Related]
3. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
Myhre L; Gautvik KM
Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma associated with hypercalcemia and ectopic secretion of calcitonin.
Heath H; Edis AJ
Ann Intern Med; 1979 Aug; 91(2):208-10. PubMed ID: 464464
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
6. Plasma-immunoreactive-calcitonin in patients with non-thyroid tumours.
Coombes RC; Hillyard C; Greenberg PB; MacIntyre I
Lancet; 1974 Jun; 1(7866):1080-3. PubMed ID: 4135248
[No Abstract] [Full Text] [Related]
7. Calcitonin in nonthyroidal cancer.
Schwartz KE; Wolfsen AR; Forster B; Odell WD
J Clin Endocrinol Metab; 1979 Sep; 49(3):438-44. PubMed ID: 468977
[TBL] [Abstract][Full Text] [Related]
8. Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer.
Kim HK; Bae WK; Choi YD; Shim HJ; Yoon JH; Kang HC
Thyroid; 2014 Mar; 24(3):599-603. PubMed ID: 23985043
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay for human calcitonin employing synthetic calcitonin M: its clinical application.
Morita R; Fukunaga M; Yamamoto I; Mori T; Torizuka K
Endocrinol Jpn; 1975 Oct; 22(5):419-26. PubMed ID: 1061670
[TBL] [Abstract][Full Text] [Related]
10. Serum calcitonin-lowering effect of magnesium in patients with medullary carcinoma of the thyroid.
Anast C; David L; Winnacker J; Glass R; Baskin W; Brubaker L; Burns T
J Clin Invest; 1975 Dec; 56(6):1615-21. PubMed ID: 1202087
[TBL] [Abstract][Full Text] [Related]
11. [Calcitonin and paratirin in nodular pathology of the thyroid gland].
Ivanov PK; Tkacheva GA; Telish VM; Karetnikov IuP
Probl Endokrinol (Mosk); 1983; 29(1):27-30. PubMed ID: 6835952
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A as tumor marker in medullary thyroid carcinoma.
Blind E; Schmidt-Gayk H; Sinn HP; O'Connor DT; Raue F
Thyroid; 1992; 2(1):5-10. PubMed ID: 1356053
[TBL] [Abstract][Full Text] [Related]
13. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
14. Determination of plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons and patients with medullary thyroid carcinoma and other neuroendocrine tumors.
Carter WB; Taylor RL; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Feb; 72(2):327-35. PubMed ID: 1991803
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
16. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
[TBL] [Abstract][Full Text] [Related]
17. Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid.
Lee S; Morimoto S; Onishi T; Tsuji M; Okada Y; Seino Y; Ishida M; Yamaoka K; Takai S; Miyauchi A; Kumahara Y
J Clin Endocrinol Metab; 1982 Aug; 55(2):361-3. PubMed ID: 6979551
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
19. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
20. [Monomeric plasmatic calcitonin and hypercalcemia in lung cancer patients].
Coifman R; Weforte RV; Kasamatsu TS; Fukusima L; Santoro I; Jamnik S; Vieira JG; Castro ML
Rev Assoc Med Bras (1992); 1997; 43(2):105-8. PubMed ID: 9336044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
